HMGB1 and B-cell chronic lymphocytic leukemia: Increased plasma or serum levels of HMGB1 have been found in various types of tumors, such as colon carcinoma, chronic lymphocytic leukemia and hepatocellular carcinoma, and promotes tumor progression [27].